Literature DB >> 9507105

Effect of the surface lipid composition of reconstituted LPA-I on apolipoprotein A-I structure and lecithin: cholesterol acyltransferase activity.

D L Sparks1, P G Frank, T A Neville.   

Abstract

Characterization of the factors that regulate plasma cholesterol esterification shows that the increased activity of lecithin:cholesterol acyltransferase (LCAT) in the plasma of hyperlipidemic subjects is due to enhanced interactions with a preferred substrate. The details of how the physical properties of high density lipoproteins (HDL) may affect their ability to stimulate cholesterol esterification by LCAT have been investigated in homogeneous reconstituted HDL particles containing two molecules of apolipoprotein (apo) A-I (Lp2A-I) and palmitoyl-oleoyl phosphatidylcholine (POPC). Increasing the POPC or sphingomyelin (SPH) content in an Lp2A-I complex increases particle size and stability but decreases the negative surface charge of apoA-I. Increasing Lp2A-I POPC or SPH content also significantly inhibits cholesterol esterification by LCAT. Increase in the maximum rate of CE production (Vmax) by LCAT is directly related to an increased negative charge on the different Lp2A-I particles and to a reduced amount and stability of amphipathic alpha-helices in apoA-I. In contrast, increasing the Lp2A-I complex negative charge directly by addition of a charged lipid, phosphatidylinositol (PI), has minimal effect on apoA-I conformation and LCAT activation. While variations in Lp2A-I PI content have little effect on the interfacial binding of LCAT, increasing POPC content appears to directly increase the binding affinity of LCAT for the different Lp2A-I particles. These results show that LCAT is stimulated by an apoA-I conformation-dependent increase in negative charge but is less sensitive to electrostatic changes in the lipid interface of discoidal Lp2A-I. The activation of LCAT appears to be dependent on the exposure of both central (residues 98-132) and N-terminal (residues 2-8) domains in apoA-I. A strong relationship between the immunoreactivity of two specific mAbs, 4H1 and A11, and LCAT reactivity suggests that the N-terminus of apoA-I may interact with a central domain in a manner that may regulate the accessibility of LCAT to the edge of the disc. This indicates that the conformation and charge of apoA-I are sensitive to the surface-lipid composition of HDL particles and play a central role in regulating LCAT activation. Since alterations in the surface lipid composition of HDL particles from hyperlipidemic subjects also modify the charge and structure of these particles, this may stimulate the rates of cholesterol esterification by making these lipoproteins preferred LCAT substrates. Copyright 1998 Elsevier Science B.V.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9507105     DOI: 10.1016/s0005-2760(97)00172-0

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  10 in total

1.  Sequence-specific apolipoprotein A-I effects on lecithin:cholesterol acyltransferase activity.

Authors:  Alexander D Dergunov
Journal:  Mol Cell Biochem       Date:  2013-03-21       Impact factor: 3.396

2.  Regulation of plasma cholesterol esterification by sphingomyelin: effect of physiological variations of plasma sphingomyelin on lecithin-cholesterol acyltransferase activity.

Authors:  Papasani Venkata Subbaiah; Xian-Cheng Jiang; Natalia A Belikova; Buzulagu Aizezi; Zhi Hua Huang; Catherine A Reardon
Journal:  Biochim Biophys Acta       Date:  2012-02-18

3.  Phospholipid Component Defines Pharmacokinetic and Pharmacodynamic Properties of Synthetic High-Density Lipoproteins.

Authors:  Maria V Fawaz; Sang Yeop Kim; Dan Li; Ran Ming; Ziyun Xia; Karl Olsen; Irina D Pogozheva; John J G Tesmer; Anna Schwendeman
Journal:  J Pharmacol Exp Ther       Date:  2019-11-27       Impact factor: 4.030

4.  Arginine 123 of apolipoprotein A-I is essential for lecithin:cholesterol acyltransferase activity.

Authors:  Irina N Gorshkova; Xiaohu Mei; David Atkinson
Journal:  J Lipid Res       Date:  2017-12-05       Impact factor: 5.922

5.  Regulation of the activity and fatty acid specificity of lecithin-cholesterol acyltransferase by sphingomyelin and its metabolites, ceramide and ceramide phosphate.

Authors:  Papasani V Subbaiah; Peter Horvath; Srinivasa B Achar
Journal:  Biochemistry       Date:  2006-04-18       Impact factor: 3.162

6.  Nascent high density lipoproteins formed by ABCA1 resemble lipid rafts and are structurally organized by three apoA-I monomers.

Authors:  Mary G Sorci-Thomas; John S Owen; Brian Fulp; Shaila Bhat; Xuewei Zhu; John S Parks; Dharika Shah; W Gray Jerome; Mark Gerelus; Manal Zabalawi; Michael J Thomas
Journal:  J Lipid Res       Date:  2012-06-29       Impact factor: 5.922

7.  Sphingolipids and Cholesterol.

Authors:  Xian-Cheng Jiang; Zhiqiang Li
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 3.650

8.  Inhibition of endothelial lipase activity by sphingomyelin in the lipoproteins.

Authors:  Peng Yang; Natalia A Belikova; Jeff Billheimer; Daniel J Rader; John S Hill; Papasani V Subbaiah
Journal:  Lipids       Date:  2014-08-29       Impact factor: 1.880

Review 9.  Lecithin:cholesterol acyltransferase: old friend or foe in atherosclerosis?

Authors:  Sandra Kunnen; Miranda Van Eck
Journal:  J Lipid Res       Date:  2012-05-07       Impact factor: 5.922

Review 10.  Sphingomyelin in high-density lipoproteins: structural role and biological function.

Authors:  Roberto Martínez-Beamonte; Jose M Lou-Bonafonte; María V Martínez-Gracia; Jesús Osada
Journal:  Int J Mol Sci       Date:  2013-04-09       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.